Xact Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2026-09-28.
Xact Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 28, 2026. The filing reports $10M sold. Its industry group is Biotechnology. It names Eric Green (Executive Officer, Director), Uciane Scarlett (Executive Officer, Director), Chengjung Lai (Director) (SEC Form D, September 28, 2026).
Sell to companies like Xact Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Xact Bio, Inc.
Free to see. No signup.
More on the people and the money behind Xact Bio, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in September 2026, largest first.
Get an email when Xact Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Xact Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Xact Bio, Inc. →Get the full cited report on Xact Bio, Inc.
What the filing shows about Xact Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Xact Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $10M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Eric Green is named as Executive Officer and Director on the Form D that Xact Bio, Inc. filed with the SEC on 28 September 2026, one of 4 people that filing names.
Uciane Scarlett is named as Executive Officer and Director on the Form D that Xact Bio, Inc. filed with the SEC on 28 September 2026, one of 4 people that filing names.
Chengjung Lai is named as Director on the Form D that Xact Bio, Inc. filed with the SEC on 28 September 2026, one of 4 people that filing names.
Jian Shao is named as Director on the Form D that Xact Bio, Inc. filed with the SEC on 28 September 2026, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2026-09-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Xact Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Xact Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Xact Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Xact Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Xact Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Xact Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-09-28 · Biotech raises in Boston
https://mentionfox.com/funding/xact-bio-inc-form-d-000001